Home » Stocks » ATAI

ATAI Life Sciences N.V. (ATAI)

ATAI Life Sciences will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) -169.84M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

ATAI Life Sciences N.V. has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About ATAI

ATAI Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. It is expected that more than 50% of the U.S. population will be diagnosed with a mental health disorder at some point in their lifetime, with increasing incidence ascribed to the COVID-19 pandemic. We founded atai Life Sciences in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooke... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Pending
CEO
Florian Brand
Employees
35
Stock Exchange
NASDAQ
Ticker Symbol
ATAI
Full Company Profile

Financial Performance

Financial Statements